Traditional Chinese medicine Lianhua Qingwen treating corona virus disease 2019(COVID-19): Meta-analysis of randomized controlled trials.

IntroductionAs the global epidemic continues to spread, countries have tapped effective drugs to treat new coronavirus pneumonia. The therapeutic effect of the traditional Chinese medicine Lianhua Qingwen in this new coronary pneumonia epidemic has attracted attention from all walks of life, and relevant research reports continue to appear. Therefore, we conducted a systematic review of the clinical efficacy and safety of the traditional Chinese medicine Lianhua Qingwen in the treatment of new coronavirus pneumonia (COVID-19) (referred to as "new coronary pneumonia"), and evaluated the overall level of research quality.MethodsWe searched seven databases and retrieved the Chinese Journal Full-text Database (CNKI), Vip Database (VIP), China Biomedicine (SinoMed), Wanfang Database and PubMed, Cochrane Central, EMBASE from October 2019 to May 2020 Literature references. We included randomized controlled trials (RCTs) that tested the efficacy of the traditional Chinese medicine lotus clearing plague in the treatment of new coronavirus pneumonia. The authors extracted data and independently assessed quality. We used Stata15.1 software to analyze the data of randomized trials.ResultsA total of 2 articles were identified, including 154 patients. All the participating patients were diagnosed with new coronavirus pneumonia (COVID-19). The meta-analysis results showed that the disappearance rate of the main clinical symptoms of Chinese medicine Lianhua Qingwen in the treatment of new coronavirus pneumonia was significantly higher than that of the control group [OR = 3.34, 95% CI (2.06, 5.44), P ConclusionThe treatment of new pneumonia with traditional Chinese medicine lotus clearing plague can be used as an effective therapy to improve the clinical symptoms of new coronary pneumonia. More rigorous design, multi-center, and prospective RCTs are necessary to further determine the effectiveness and safety of the traditional Chinese medicine lotus decoction in the treatment of new pneumonia

Research on Post Investment Evaluation of Distribution Network Infrastructure Project Adapting to Transmission and Distribution Price Reform

Under the background of the continuous promotion of the current transmission and distribution price reform, the company's investment strategy is constantly inclined to the distribution network, so it is more important to evaluate the implementation process and effect of its investment. Therefore, on the basis of the current distribution network post evaluation work, it is urgent to adjust the project investment post evaluation index system adaptively, and strengthen its application in investment management, so as to give play to its greater value in the company's investment lean management. For this reason, combined with the requirements of the current transmission and distribution price reform, this paper puts forward two suggestions for the current post evaluation work: first, to adapt to the transmission and distribution price reform, it is suggested to optimize the existing indicators and improve the adaptability of post evaluation work; second, it is suggested to strengthen the application of post evaluation results. Through the optimization of the above two points, the closed-loop investment management of distribution network project is formed, and the efficiency of investment management is improved